• 1
    Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 17251730.
  • 2
    Mocroft A, Brettle R, Kirk O et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002; 16: 16631671.
  • 3
    Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6: 99106.
  • 4
    Lewden C, Salmon D, Morlat P et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34: 121130.
  • 5
    Weber R, Sabin CA, Friis-Moller N et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 16321641.
  • 6
    Palella FJ, Jr, Baker RK, Moorman AC et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 2734.
  • 7
    Monforte A, Abrams D, Pradier C et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008; 22: 21432153.
  • 8
    Lewden C, May T, Rosenthal E et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the ‘Mortalite 2000 and 2005’ surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008; 48: 590598.
  • 9
    Smith C, Sabin CA, Lundgren JD et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24: 15371548.
  • 10
    Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50: 13871396.
  • 11
    Hasse B, Ledergerber B, Furrer H et al. Morbidity and Aging in HIV-Infected Persons: the Swiss HIV Cohort Study. Clin Infect Dis 2011; 53: 11301139.
  • 12
    Jaggy C, von Overbeck J, Ledergerber B et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362: 877878.
  • 13
    Keiser O, Taffe P, Zwahlen M et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 2004; 18: 18351843.
  • 14
    van Sighem A, Danner S, Ghani AC, Gras L. Anderson RM and de Wolf F. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals. J Acquir Immune Defic Syndr 2005; 40: 212218.
  • 15
    Kovari H, Ledergerber B, Peter U et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009; 49: 626635.
  • 16
    Kowalska JD, Friis-Moller N, Kirk O et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology 2011; 22: 516523.
  • 17
    Hernando V, Sobrino-Vegas P, Burriel M et al. Differences in the cause of death in HIV-infected patients in the Spanish AIDS Research Cohort (CoRIS) according to data sources and coding algorithms. 13th European AIDS Conference. Belgrade, Serbia, 2011 [Abstract PS11/13].
  • 18
    CoDe Working Group. Coding Causes of Death in HIV Protocol Version 1.0. CoDe Website. Available at (accessed 20 October 2011).
  • 19
    Bopp M, Spoerri A, Zwahlen M et al. Cohort Profile: the Swiss National Cohort–a longitudinal study of 6.8 million people. Int J Epidemiol 2009; 38: 379384.
  • 20
    Schoeni-Affolter F, Ledergerber B, Rickenbach M et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 2010; 39: 11791189.
  • 21
    D:A:D Study Group. Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D): manual of Operations, Version 1.3 (February 2005). Available at (accessed 20 October 2011).
  • 22
    Centers for Disease Control (CDC). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 119.
  • 23
    Centers for Disease Control (CDC). Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep 1986; 35: 334339.
  • 24
    World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version 2010. Available at (accessed 20 October 2011).
  • 25
    Spoerri A, Zwahlen M, Egger M, Bopp M. The Swiss National Cohort: a unique database for national and international researchers. Int J Public Health 2010; 55: 239242.
  • 26
    The Swiss Federal Statistical Office. Mortality, causes of death: Data, indicators. Available at (accessed 30 August 2012).
  • 27
    Fair M. Generalized Record Linkage System – Statistics Canada's Record Linkage Software. Aust J Stat 2004; 33: 3753.
  • 28
    Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4: 8790.
  • 29
    Bonnet F, Morlat P, Chene G et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med 2002; 3: 195199.
  • 30
    Mocroft A, Gatell J, Reiss P et al. Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy. AIDS 2004; 18: 23332337.
  • 31
    Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006; 145: 397406.
  • 32
    Lifson AR, Belloso WH, Carey C et al. Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials 2008; 9: 177185.
  • 33
    Hessamfar-Bonarek M, Morlat P, Salmon D et al. Causes of death in HIV-infected women: persistent role of AIDS. The ‘Mortalite 2000 & 2005’ Surveys (ANRS EN19). Int J Epidemiol 2010; 39: 135146.
  • 34
    Murray M, Hogg R, Lima V et al. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Med 2012; 13: 8997.
  • 35
    Salmon-Ceron D, Rosenthal E, Lewden C et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French national Mortalite 2005 study. J Hepatol 2009; 50: 736745.
  • 36
    Rubin MS, Colen CG, Link BG. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective. Am J Public Health 2010; 100: 10531059.
  • 37
    Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD. Clinical and behavioral characteristics of adults receiving medical care for HIV infection — Medical Monitoring Project, United States, 2007. MMWR Surveill Summ 2011; 60: 120.
  • 38
    Palella FJ Jr, Baker RK, Buchacz K et al. Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS 2011; 25: 18651876.
  • 39
    Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology 2005; 47: 551559.
  • 40
    Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA. Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Crit Care 2007; 11: R48.
  • 41
    Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, Colebunders R. Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 2010; 12: 183194.
  • 42
    Justice AC. Commentary: treated HIV infection is a chronic disease: the case against cause of death analyses. Int J Epidemiol 2010; 39: 146148.
  • 43
    Johansson LA, Westerling R. Comparing hospital discharge records with death certificates: can the differences be explained? J Epidemiol Community Health 2002; 56: 301308.
  • 44
    Villar J, Perez-Mendez L. Evaluating an educational intervention to improve the accuracy of death certification among trainees from various specialties. BMC Health Serv Res 2007; 7: 183.
  • 45
    Minder C, Zingg W. Die Sterblichkeitsstatistik in der Schweiz. Amliche Statistik der Schweiz No. 155. Bern: Bundesamt für Statistik; 1989.
  • 46
    Lahti RA, Penttila A. Cause-of-death query in validation of death certification by expert panel; effects on mortality statistics in Finland, 1995. Forensic Sci Int 2003; 131: 113124.
  • 47
    Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J 2006; 28: 781785.